WallStSmart
HOTH

Hoth Therapeutics Inc

NASDAQ: HOTH · HEALTHCARE · BIOTECHNOLOGY

$0.66
-23.35% today

Updated 2026-06-05

Market cap
$12.62M
P/E ratio
P/S ratio
EPS (TTM)
$-0.90
Dividend yield
52W range
$0 – $2
Volume
10.0M

Hoth Therapeutics Inc (HOTH) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$188.00$28252.00$31622.00$25871.00$46.87M$66834.00
Gross profit$-188.00$-28252.00$-31622.00$-25871.00$-46.87M$-66834.00
Gross margin
R&D$586843.00$1.02M$2.12M$2.89M$7.53M$4.93M$3.48M$3.25M$5.95M
SG&A$320123.00$1.22M$5.06M$2.93M$6.57M$6.13M$4.21M$4.97M$6.41M
Operating income$-1.87M$-2.50M$-7.71M$-7.30M$-14.10M$-11.07M$-7.69M$-8.22M$-11.11M
Operating margin
EBITDA$-2.02M$-2.49M$-7.71M$-7.30M$-14.31M$-10.68M$-153149.00$27132.00$-11.11M
EBITDA margin
EBIT$-2.02M$-2.50M$-7.71M$-7.30M$-14.10M$-21.74M$-7.85M$-8.19M
Interest expense$0.00$0.00$0.00$0.00$212265.00$305409.00
Income tax$2.00$-159917.00$-10361.00$-205254.00$212265.00$305409.00$-7692.00
Effective tax rate-0.0%6.0%0.1%2.8%-1.5%-2.8%0.1%0.0%0.0%
Net income$-2.02M$-2.50M$-7.69M$-7.20M$-14.31M$-11.37M$-7.85M$-8.19M$-12.47M
Net income growth (YoY)-23.8%-208.3%+6.5%-98.9%+20.6%+31.0%-4.4%-52.3%
Profit margin

Frequently asked questions

How much free cash flow does HOTH generate?

HOTH produced $-9.80M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is HOTH's balance sheet healthy?

HOTH holds $7.04M in cash and equivalents against — in long-term debt, on $6.88M of shareholder equity. That debt is best read against the cash flow the business throws off each year.